INSPIRE VETERINARY PARTNERS, INC.
IVPRdata completeness 88%3 fiscal years on fileData notes: no data for concept 'epsDiluted'; no data for concept 'interestExpense'
The thesis, from the filings
INSPIRE VETERINARY PARTNERS, INC. earns about -913% on equity. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
i. The business — what you’d actually own
| Figure | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Revenue | $9.83M1 | $16.7M2 | $16.6M2 |
| Net income | −$4.91M3 | −$14.8M4 | −$14.3M4 |
| Operating cash flow | −$2.66M5 | −$3.82M6 | −$10M6 |
| Capital expenditure | $134,9717 | $383,7308 | $237,9838 |
| Free cash flow (derived) | −$2.79M5 | −$4.2M6 | −$10.2M6 |
| Total debt | — | — | $12M9 |
| Cash & equivalents | $444,25310 | $178,96111 | $523,69011 |
| Diluted shares | — | — | — |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
iii. Is this a good business?
Moat signal · return on equity
-913% avg · 3y
FY22 —FY23 —FY24 -913%
It earned an average -913% on equity over 3 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Management signal · capital allocation
— shares · 3y
Total debt has held roughly steady.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined
Different models answer different questions — which to trust when →
Sources — the receipts
- 10-K · period ending 2022-12-31 · accession 0001213900-24-031220 (Revenues)
- 10-K · period ending 2023-12-31 · accession 0001213900-25-026232 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001213900-24-031220 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001213900-25-026232 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001213900-24-031220 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001213900-25-026232 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001213900-24-031220 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001213900-25-026232 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001213900-25-026232 (LongTermDebt)
- 10-K · period ending 2022-12-31 · accession 0001213900-24-031220 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001213900-25-026232 (CashAndCashEquivalentsAtCarryingValue)